Nifedipine — Discount Pricing
Nifedipine is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Nifedipine Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $109.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Nifedipine
Nifedipine is a prescription medication. Ask your doctor if Nifedipine is right for you.
Other strengths and forms of Nifedipine
How to Check Nifedipine Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Nifedipine at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Heart & Cardiovascular
About Nifedipine
Nifedipine is a calcium channel blocker commonly prescribed to treat high blood pressure and chest pain (angina). This medication helps relax blood vessels, improving blood flow and reducing strain on the heart. Without insurance or discount programs, nifedipine can be expensive. TheDrugClub members access this essential medication at $0 co-pay with free home delivery, making heart health management truly affordable.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Nifedipine is approved for (FDA label)
I.Vasospastic Angina Nifedipine extended-release tablets are indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by ST segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. In those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied.
Source: Read the full FDA label on DailyMed. Label effective date: August 4, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Nifedipine (FDA label)
ADVERSE EXPERIENCES Over 1000 patients from both controlled and open trials with nifedipine extended-release tablets in hypertension and angina were included in the evaluation of adverse experiences. All side effects reported during nifedipine extended-release tablets therapy were tabulated independent of their causal relation to medication. The most common side effect reported with nifedipine extended-release tablets was edema which was dose related and ranged in frequency from approximately 10% to about 30% at the highest dose studied (180 mg). Other common adverse experiences reported in placebo-controlled trials include: Of these, only edema and headache were more common in nifedipine extended-release tablets patients than placebo patients.
Source: FDA prescribing information (DailyMed). Set ID: 4ee466dc-5a4e-4c77-8e94-8b510cafd61b. SPL document ID: d2a3cbad-62f3-4db1-96c4-da28631477a0. Label effective date: August 4, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.